AFP and hepatocellular carcinoma: Moreover, a study conducted by Kaibori et al. [144] revealed that a high score of the pre-treatment serum modified ALB–BIL grade combined with pre-treatment serum AFP level was a factor that was independently correlated with worse OS and RFS in HCC patients treated with curative surgical resection.